Long
Molecular Coin (MOF) 80% or 120% Easy & Fast!
Molecular Coin (MOFBTC) printed the Cup & Handle bullish chart pattern and has already gone up.
Today we see prices growing after closing above EMA100, with plenty of room left for additional gains.
Our first target is set at 0.618 Fib. extension or EMA200 at 0.00001300 satoshis, for a nice 80% in potential profits.
The next target is set at 120% of profits right above this one at 0.00001577.
This is not financial advice.
Enjoy the trade.
Namaste.
Today we see prices growing after closing above EMA100, with plenty of room left for additional gains.
Our first target is set at 0.618 Fib. extension or EMA200 at 0.00001300 satoshis, for a nice 80% in potential profits.
The next target is set at 120% of profits right above this one at 0.00001577.
This is not financial advice.
Enjoy the trade.
Namaste.
Note
Extreme bullishness!Note
We keep on growing.I am aiming above the 80% marked on the chart :D
Enjoy.
🚨 FREE PREMIUM Trades + Top Results
t.me/anandatrades/1183
🚨 FREE Quality Content + New Results
(Frequent Discounts & Offers)
t.me/masteranandatrades/6172
🚨 Go beyond! PREMIUM LIFETIME Access
lamatrades.com (Since 2017)
t.me/anandatrades/1183
🚨 FREE Quality Content + New Results
(Frequent Discounts & Offers)
t.me/masteranandatrades/6172
🚨 Go beyond! PREMIUM LIFETIME Access
lamatrades.com (Since 2017)
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
🚨 FREE PREMIUM Trades + Top Results
t.me/anandatrades/1183
🚨 FREE Quality Content + New Results
(Frequent Discounts & Offers)
t.me/masteranandatrades/6172
🚨 Go beyond! PREMIUM LIFETIME Access
lamatrades.com (Since 2017)
t.me/anandatrades/1183
🚨 FREE Quality Content + New Results
(Frequent Discounts & Offers)
t.me/masteranandatrades/6172
🚨 Go beyond! PREMIUM LIFETIME Access
lamatrades.com (Since 2017)
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.